Product Information
NYSTATIN-TRIAMCINOLONE CREAM is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1916 per GM under NDC 33342048260. Its NADAC has been published 114 times since Jul 31, 2024.
FDA first approved this application on Jul 13, 2022. Its Orange Book therapeutic-equivalence code is AT.
Strength
100000; 1 [USP'U]/g; mg/g
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342048260
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
NYSTATIN; TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214181FDA Approved
7/13/2022
TE Code
AT
On Market Since
8/31/2022
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN-TRIAMCINOLONE CREAM has been published 114 times since Jul 31, 2024, and over the history we have for it it has declined 6.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1916 per GM |
|---|---|
| All-time high | $0.2956 (Oct 16, 2024) |
| All-time low | $0.1818 (Nov 20, 2024) |
| 52-week high | $0.2157 |
| 52-week low | $0.1893 |
| Median price | $0.2076 |
| Average price | $0.2179 |
| Largest weekly change | +40.9% (Aug 21, 2024) |
| Weeks tracked | 114 |
| Tracking since | Jul 31, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nystatin and triamcinolone acetonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NYSTATIN-TRIAMCINOLONE CREAM?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN-TRIAMCINOLONE CREAM, manufactured by Macleods Pharmaceuticals Limited, is $0.1916 per GM (NDC 33342048260), effective Sep 30, 2026.
How has the price of NYSTATIN-TRIAMCINOLONE CREAM changed over time?
Over the history we have for it, the NADAC for NYSTATIN-TRIAMCINOLONE CREAM has declined 6.7%. It has been tracked across 114 weekly CMS publications since Jul 31, 2024.
What are the highest and lowest recorded NADAC prices for NYSTATIN-TRIAMCINOLONE CREAM?
Since Jul 31, 2024, the NADAC for NYSTATIN-TRIAMCINOLONE CREAM has ranged from a low of $0.1818 (Nov 20, 2024) to a high of $0.2956 (Oct 16, 2024), with a median of $0.2076 per GM.
Are there cheaper alternatives to NYSTATIN-TRIAMCINOLONE CREAM?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NYSTATIN-TRIAMCINOLONE CREAM in a comparable dosage form, but none are currently priced below it.
Who manufactures NYSTATIN-TRIAMCINOLONE CREAM?
NYSTATIN-TRIAMCINOLONE CREAM (NDC 33342048260) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.